Unknown NA INTERVENTIONAL 2-arm NCT06182098

Intravenous Fluids in Pediatric Migraine

Value of Intravenous Fluids in the Emergent Treatment of Pediatric Migraine

Sponsor: Dayton Children's Hospital

Conditions Migraine Migraine in Children

Interventions 1/2 maintenance fluids Diphenhydramine Ketorolac Prochlorperazine bolus

Updated 4 times since 2024 Last updated: Dec 13, 2023 Started: Jun 27, 2023 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Migraine and Migraine in Children, this trial is ongoing. The trial is conducted by Dayton Children's Hospital and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dayton Children's Hospital

Data source: Dayton Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dayton, United States